Loading news...
James P. Zallie sold 9,958 shares for a transaction value of ~$1.16 million based on the reported price of $116.55 per share on Feb. 18, 2026. This sale represented 23.2% of Zallie's direct holdings, reducing his direct stake from 42,968 to 33,010 shares.
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR).
Hillsdale Investment Management Inc. boosted its holdings in Ingredion Incorporated (NYSE: INGR) by 26.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,830 shares of the company's stock after acquiring an additional 6,100 shares during the quarter. Hillsdale Investment Management Inc.'s holdings
Dover Advisors LLC bought a new stake in Ingredion Incorporated (NYSE: INGR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 14,000 shares of the company's stock, valued at approximately $1,710,000. A number of other large investors also recently bought and sold
Ingredion's President and CEO sold 33,597 direct shares for a transaction value of approximately $4.02 million on Feb. 11, 2026. The sale represented 40.11% of Mr.
The packaged foods industry has broadly declined over the last year with some producers dropping over 20%; dividend yields have expanded to as much as 9.5%. However, a high dividend yield does might not indicate value, profitability, or financial strength. Twenty-three high yield packaged food producers we compared on a matrix of factors including yield, payout ratio, value, growth, profitability, and debt.
Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
Envestnet Asset Management Inc. lowered its stake in shares of Ingredion Incorporated (NYSE: INGR) by 4.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 193,709 shares of the company's stock after selling 8,905 shares during the quarter. Envestnet Asset
WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately.
Ingredion is reiterated as a Buy, supported by strong financial health and robust free cash flow exceeding guidance. INGR advances strategic pillars—protein and clean label ingredients—while completing its Cost2Compete program, achieving $59M in run-rate savings. 2026 guidance calls for low- to mid-single-digit net sales growth, EPS of $11–$11.80, and free cash flow midpoint of $460M.
Ingredion Incorporated (INGR) Q4 2025 Earnings Call Transcript
Ingredion Incorporated delivered resilient profitability and has a strong balance sheet despite flat sales and US/Canada production setbacks. INGR guidance for 2024 is cautious: EPS of $11.00-$11.80, low-to-mid single-digit sales growth, and modest operating income improvement. Operational efficiency initiatives and R&D focus on Clean Labels and plant-based ingredients position INGR for future margin expansion.
Ingredion (INGR) came out with quarterly earnings of $2.53 per share, missing the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.63 per share a year ago.
Reported and adjusted* EPS were $11.18 and $11.13 for full-year 2025, compared with $9.71 and $10.65 for full-year 2024 Cash from operations was $944 million for the full-year 2025, during which the Company returned $435 million to shareholders, including $224 million of share repurchases The Company expects its full-year 2026 outlook for reported and adjusted EPS to be in the range of $11.00 to $11.80 WESTCHESTER, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its fourth quarter 2025 and full-year 2025 results.
Cooke and Bieler LP raised its holdings in shares of Ingredion Incorporated (NYSE: INGR) by 16.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 903,346 shares of the company's stock after purchasing an additional 124,517 shares during the
WESTCHESTER, Ill., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, has been certified as a Top Employer in eight countries and as a Top Employer in the Asia Pacific region.
Ingredion was named to the 2026 FORTUNE World's Most Admired Companies list for the 16th time, recognized for innovation, excellence and sustainability.
WESTCHESTER, Ill., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before the market opens Tuesday, February 3, 2026.
BEDFORD PARK, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today unveiled its first-ever custom-designed railcar wrap to support the American Heart Association and promote heart health.
Ingredion Incorporated (NYSE: INGR - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among analysts